Sugi Predict

Sugi Predict / Targets / HNRNPLL

HNRNPLL

Heterogeneous nuclear ribonucleoprotein L-like · Q8WVV9 · HNRNPLL on Sugi Atlas →

0 patent compounds predicted against HNRNPLL, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to HNRNPLL by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors PHASE1ACTIVE_NOT_RECRUITING
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Longitudinal Study of Neurogenetic Disorders nanRECRUITING
Diagnosis of Inflammatory Bowel Disease nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Assessment Of Long Noncoding RNA CCAT1 In Colorectal Cancer Patients nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis nanRECRUITING
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
EKLF Gene Expression in β-thalassemia nanNOT_YET_RECRUITING
Liquid Biopsy for Early Detection of Colorectal Cancer Using Circular RNA nanRECRUITING
Effect of Migalastat on Cardiac Involvement in Fabry Disease nanCOMPLETED
Risk of HCC in Cirrhotic Patients Post DAAs Ttt nanUNKNOWN
Na+ Channel mRNA Regulation in Heart Failure nanCOMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED
Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma nanACTIVE_NOT_RECRUITING
Clinical and Genetic Examinations of Dilated Cardiomyopathy nanCOMPLETED
Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients nanRECRUITING
Progression Follow up of the First-degree Relatives of Patients With REM Sleep Behavior Disorder nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a HNRNPLL binder may also engage these)

ProteinNameSimilarity
Q921F4 — 1.000 Q921F4 →
HNRNPL Heterogeneous nuclear ribonucleoprotein L 0.986 landscape →
F1LQ48 — 0.985 F1LQ48 →
Q8R081 — 0.984 Q8R081 →
Q6NXG1 — 0.969 Q6NXG1 →
Q7ZY29 — 0.969 Q7ZY29 →
B2RYD2 — 0.968 B2RYD2 →
Q9MAC5 — 0.967 Q9MAC5 →
Q3US41 — 0.962 Q3US41 →
Q6DEZ7 — 0.962 Q6DEZ7 →
Q62696 — 0.960 Q62696 →
Q5PYH7 — 0.958 Q5PYH7 →
Q794E4 — 0.957 Q794E4 →
Q8BWW9 — 0.957 Q8BWW9 →
PRKD1 Serine/threonine-protein kinase D1 0.956 landscape →
Q60HC3 — 0.955 Q60HC3 →
Q8K1Y2 — 0.955 Q8K1Y2 →
Q9ERG2 — 0.954 Q9ERG2 →
Q5R5W2 — 0.954 Q5R5W2 →
Q5E9J1 — 0.953 Q5E9J1 →
Q91YE7 — 0.953 Q91YE7 →
Q9BYZ6 — 0.953 Q9BYZ6 →
Q1RMU5 — 0.952 Q1RMU5 →
Q15700 — 0.952 Q15700 →
Q28C55 — 0.952 Q28C55 →
Q3ZC15 — 0.952 Q3ZC15 →
Q5XIS9 — 0.952 Q5XIS9 →
Q5PYH6 — 0.951 Q5PYH6 →
Q640Z1 — 0.951 Q640Z1 →
Q1JQ73 — 0.951 Q1JQ73 →